HWAIF (Healwell AI) Short Ratio


HWAIF Healwell AI Inc HWAIF
53 GF Score
Price $0.54
GF Value $2.54
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Healwell AI Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HWAIF
53GF Score
Healwell AI Inc HWAIF
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Healwell AI (HWAIF) Overvalued in 2026?

Based on GuruFocus' analysis, Healwell AI stock appears to be undervalued. The current stock price of $0.54 is trading 78.7% below its estimated GF Value™ of $2.54. GuruFocus considers Healwell AI to be Possible Value Trap.

Key valuation signals for HWAIF:

  • Short Ratio:
  • GF Value™: $2.54 vs. price of $0.54 (78.7% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the HWAIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healwell AI Business Description

Other Exchanges 6H90:GermanyAIDX:Canada
Address 460 College Street, Unit 301, Toronto, ON, CAN, M6G 1A1
Healwell AI Inc is a Canadian healthcare technology company. It operates in two reportable segments: Al and Data Sciences, and Healthcare Software. The majority of Healwell's revenue is generated from the Healthcare Software segment, whose core software suite consists of Electronic Health Records (EHR), Digital Front Door (DFD), and Digital Care Records (DCR). These products consolidate diverse data sources, helping physicians get a comprehensive view of individual patient health. The AI and Data Sciences division offers AI technologies and algorithms that screen clinical information and patient records, and aid in identifying patients at high risk for specific conditions. Geographically, the company generates maximum revenue from Australia and New Zealand, and the rest from Canada.
53GF Score

Get the complete analysis for HWAIF

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.54
Price
$2.54
GF Value